Literature DB >> 32088653

Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare.

Bingxin Shi1, Wei Jiang2, Mianwang He3, Hui Sun3, Xuan Sun4, Yang Yang4, Jiarui Yao4, Lei Wu5, Dehui Huang6.   

Abstract

BACKGROUND: Inflammatory demyelinating disease of the central nervous system characterized by aseptic meningitis is rare and can be easily confused with intracranial infection. Here, we investigated the clinical features of neuromyelitis optica spectrum disorder (NMOSD) patients with a meningitis-like presentation.
METHODS: From a total of six attacks, five patients were identified. Their demographic, clinical, and magnetic resonance imaging (MRI) findings, as well as treatments and prognoses were retrospectively analyzed.
RESULTS: Five patients (two males with myelin oligodendrocyte glycoprotein [MOG] antibody and three females with aquaporin-4 [AQP4] antibody) experienced six attacks. Average age at onset was 31.5 ± 3.5 years-old. The earliest clinical manifestations included fever (6/6), headache (5/6), and meningeal irritation (6/6) accompanied by leukocytosis and elevated protein levels (6/6) in cerebrospinal fluid. Two attacks initially manifested as meningitis alone. Meanwhile, following the onset of meningitis-like symptoms, four attacks were accompanied by transverse myelitis on the same day. One attack was associated with leptomeningeal enhancement on MRI, four attacks with spinal meninges enhancement, and one with both leptomeningeal and spinal meninges enhancement. All patients were considered to have an intracranial infection at onset and consequently treated with anti-infective drugs. As the symptoms continuously deteriorated, flare-up of NMOSD was considered a more reasonable diagnosis. Application of glucocorticoids (with or without intravenous immunoglobulin therapy) quickly relieved the symptoms. Subsequent re-examination of cerebrospinal fluid and MRI showed significant improvements.
CONCLUSION: Aseptic meningitis may be an atypical phenotype of NMOSD flare that is easily confused with specific infection. Comprehensive evaluation to exclude an infective etiology and enable accurate diagnosis and timely immunotherapy are critical to prognosis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aquaporin-4; Aseptic meningitis; Myelin oligodendrocyte glycoprotein; Neuromyelitis optica spectrum disorder

Mesh:

Substances:

Year:  2020        PMID: 32088653     DOI: 10.1016/j.msard.2020.102013

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  4 in total

1.  Case Report: Neuromyelitis Optica Spectrum Disorder With Progressive Elevation of Cerebrospinal Fluid Cell Count and Protein Level Mimicking Infectious Meningomyelitis: A Diagnostic Challenge.

Authors:  Yin-Xi Zhang; Meng-Ting Cai; Ming-Xia He; Yu-Qiang Lu; Xiao Luo; Tian-Yi Zhang
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

2.  Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder.

Authors:  Haojie Xie; Yingzhe Shao; Juan Du; Yajun Song; Yanfei Li; Ranran Duan; Yaobing Yao; Zhe Gong; Junfang Teng; Yanjie Jia
Journal:  J Neurol       Date:  2021-08-12       Impact factor: 4.849

3.  Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report.

Authors:  Chenyang Zhang; Kang Zhang; Bing Chen; Jiao Yin; Miaomiao Dong; Yixin Qin; Xiao Yang
Journal:  BMC Neurol       Date:  2021-03-09       Impact factor: 2.474

Review 4.  Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD).

Authors:  Yunjie Li; Xia Liu; Jingxuan Wang; Chao Pan; Zhouping Tang
Journal:  Front Aging Neurosci       Date:  2022-03-15       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.